Mallory Morales - Sep 15, 2024 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Chief Accounting Officer
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Mallory Morales
Stock symbol
IMRX
Transactions as of
Sep 15, 2024
Transactions value $
$7,238
Form type
4
Date filed
9/17/2024, 04:09 PM
Previous filing
May 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Award $7.24K +4.46K +53.85% $1.62 12.7K Sep 15, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the "ESPP"), for the ESPP purchase period of March 15, 2024 through September 15, 2024. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934.
F2 The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of September 15, 2024.
F3 In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Enrollment Date (as defined in the ESPP) of March 15, 2024.